DK117491D0 - Vaccine imod meningococcussygdomme, deri indgaaende komponenter, disses anvendelse og rekombinanter, som eksprimerer dem - Google Patents
Vaccine imod meningococcussygdomme, deri indgaaende komponenter, disses anvendelse og rekombinanter, som eksprimerer demInfo
- Publication number
- DK117491D0 DK117491D0 DK911174A DK117491A DK117491D0 DK 117491 D0 DK117491 D0 DK 117491D0 DK 911174 A DK911174 A DK 911174A DK 117491 A DK117491 A DK 117491A DK 117491 D0 DK117491 D0 DK 117491D0
- Authority
- DK
- Denmark
- Prior art keywords
- meningococus
- diseases
- components
- vaccine against
- recombinants expressing
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 101710116435 Outer membrane protein Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 208000037941 meningococcal disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8803111A NL8803111A (nl) | 1988-12-19 | 1988-12-19 | Multivalent meningococcen klasse i buitenmembraaneiwit vaccin. |
NL8803111 | 1988-12-19 | ||
NL8900036 | 1989-01-06 | ||
NL8900036A NL8900036A (nl) | 1988-12-19 | 1989-01-06 | Multivalent meningococcen klasse 1 buitenmembraaneiwit vaccin. |
NL8901612A NL8901612A (nl) | 1988-12-19 | 1989-06-26 | Multivalent meningococcen klasse i buitenmembraaneiwit vaccin. |
NL8901612 | 1989-06-26 | ||
PCT/US1989/005678 WO1990006696A2 (en) | 1988-12-19 | 1989-12-19 | Meningococcal class 1 outer-membrane protein vaccine |
US8905678 | 1989-12-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK117491D0 true DK117491D0 (da) | 1991-06-18 |
DK117491A DK117491A (da) | 1991-08-15 |
DK175788B1 DK175788B1 (da) | 2005-02-21 |
Family
ID=27352237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199101174A DK175788B1 (da) | 1988-12-19 | 1991-06-18 | Vaccine imod meningococcussygdomme, deri indgående komponenter, disses anvendelse og rekombinanter, som eksprimerer dem |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0449958B9 (da) |
JP (1) | JP3436756B2 (da) |
AT (1) | ATE120093T1 (da) |
AU (1) | AU640118B2 (da) |
DE (1) | DE68921895T3 (da) |
DK (1) | DK175788B1 (da) |
ES (1) | ES2070312T5 (da) |
FI (1) | FI113009B (da) |
NO (1) | NO305463B1 (da) |
WO (1) | WO1990006696A2 (da) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7118757B1 (en) | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
NZ239643A (en) * | 1990-09-17 | 1996-05-28 | North American Vaccine Inc | Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group. |
EP0967279B1 (en) | 1992-03-02 | 2008-01-02 | Novartis Vaccines and Diagnostics S.r.l. | Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
NL9201716A (nl) * | 1992-10-02 | 1994-05-02 | Nederlanden Staat | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
JPH08505128A (ja) * | 1992-10-26 | 1996-06-04 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ,アズ リプリゼンテッド バイ ザ セクレタリー,デパートメント オブ ヘルス アンド ヒューマン サービシーズ | NeisseriagonorrhoeaeおよびNeisseriameningitidisに対する免疫感作 |
PT624376E (pt) | 1993-05-13 | 2000-07-31 | American Cyanamid Co | Preparacao e utilizacoes de proteinas de membranas externas deficitarias em los de cocos gram-negativos |
US5439808A (en) * | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
US6153406A (en) * | 1993-07-23 | 2000-11-28 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B |
US5747287A (en) * | 1995-04-28 | 1998-05-05 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
US5811102A (en) | 1995-06-07 | 1998-09-22 | National Research Council Of Canada | Modified meningococcal polysaccharide conjugate vaccines |
CA2182637A1 (en) * | 1995-08-04 | 1997-02-05 | Jagath L. Kadurugamuwa | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing them |
US20020028215A1 (en) | 1999-08-09 | 2002-03-07 | Jagath L. Kadurugamuwa | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
PL325604A1 (en) * | 1995-09-18 | 1998-08-03 | Us Army Med Res Mat Command | Improved methods of obtaining non-covalently complexed and multvalent proteosomal subunitary vaccines |
EP0909323B1 (en) | 1996-01-04 | 2007-02-28 | Novartis Vaccines and Diagnostics, Inc. | Helicobacter pylori bacterioferritin |
GB9611673D0 (en) * | 1996-06-05 | 1996-08-07 | Peptide Therapeutics Ltd | Meningococcal vaccine |
JP4150082B2 (ja) | 1996-08-27 | 2008-09-17 | カイロン コーポレイション | 独特の髄膜炎菌性bエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用 |
US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
GB9701489D0 (en) | 1997-01-24 | 1997-03-12 | Auspharm Int Ltd | Antigen |
EP2261347A3 (en) * | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
CA2332963C (en) * | 1998-05-29 | 2013-07-23 | Chiron Corporation | Combination meningitidis b/c vaccines |
EP1741443B1 (en) * | 1998-05-29 | 2014-05-21 | Novartis Vaccines and Diagnostics, Inc. | Combination meningitidis B/C vaccines |
AU2003213540B8 (en) * | 1998-05-29 | 2006-09-28 | Novartis Vaccines And Diagnostic Inc. | Combination meningitidis B/C vaccines |
GB9814902D0 (en) * | 1998-07-10 | 1998-09-09 | Univ Nottingham | Screening of neisserial vaccine candidates against pathogenic neisseria |
US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
US6693186B2 (en) * | 1998-09-01 | 2004-02-17 | Antex Biologics Inc | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
US6756493B1 (en) | 1998-09-01 | 2004-06-29 | Antex Biologics, Inc. | Nucleic acid sequence and uses thereof |
US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
CA2359492A1 (en) | 1999-01-15 | 2000-07-20 | Smithkline Beecham Biologicals S.A. | Neisseria meningitidis antigen |
NZ581940A (en) | 1999-04-30 | 2011-07-29 | Novartis Vaccines & Diagnostic | Conserved neisserial antigens |
EP1069133A1 (en) * | 1999-07-13 | 2001-01-17 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neisseria meningitidis compounds and anti-infection applications thereof |
GB9916529D0 (en) * | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
CN1433470A (zh) * | 1999-10-29 | 2003-07-30 | 启龙股份公司 | 奈瑟球菌的抗原性肽 |
JP4840956B2 (ja) * | 1999-11-29 | 2011-12-21 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | 85kDaのナイセリア抗原 |
GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
DK1112747T3 (da) * | 1999-12-28 | 2004-10-25 | Akzo Nobel Nv | Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller |
DK1248647T3 (da) * | 2000-01-17 | 2010-09-27 | Novartis Vaccines & Diagnostic | Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner |
NZ520445A (en) * | 2000-01-25 | 2004-02-27 | Univ Queensland | Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA |
PT1947187E (pt) | 2000-02-28 | 2011-07-04 | Novartis Vaccines & Diagnostic | Expressões híbridas de proteínas de neisseria |
MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB0103170D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
EP2332581B1 (en) | 2001-01-23 | 2015-07-01 | Sanofi Pasteur Inc. | Tri- or tetravalent meningococcal polysaccharide-CRM197 conjugate vaccine |
WO2002083711A2 (en) | 2001-04-17 | 2002-10-24 | Chiron Corporation | Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
GB0115176D0 (en) | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
US7405039B2 (en) | 2002-02-07 | 2008-07-29 | Austin Health | Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
EP2455390A1 (en) | 2002-04-12 | 2012-05-23 | Melbourne Health | Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
SI2351579T1 (sl) | 2002-10-11 | 2017-05-31 | Glaxosmithkline Biologicals Sa | Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam |
AU2003295520B8 (en) | 2002-11-12 | 2011-05-19 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for Staphylococcal infections |
AU2003290867A1 (en) | 2002-11-12 | 2004-06-03 | The Brigham And Women's Hospital, Inc. | Methods and products for treating staphylococcal infections |
US20070059329A1 (en) | 2002-11-15 | 2007-03-15 | Nathalie Norais | Unexpected surface proteins in meningococcus |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CN101926988B (zh) | 2003-01-30 | 2014-06-04 | 诺华疫苗和诊断有限公司 | 抗多种脑膜炎球菌血清组的可注射性疫苗 |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
WO2005042564A1 (en) * | 2003-10-20 | 2005-05-12 | Sidney Kimmel Cancer Center | Flagellin fusion proteins as adjuvants or vaccines and methods of use |
ES2415358T3 (es) | 2004-04-21 | 2013-07-25 | The Brigham And Women's Hospital, Inc. | Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos |
GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
PT2682126T (pt) | 2005-01-27 | 2017-02-28 | Children`S Hospital & Res Center At Oakland | Vacinas de vesícula com base em agn1870 para proteção de amplo espetro contra doenças causadas por neisseria meningitidis |
US8211443B2 (en) | 2005-04-08 | 2012-07-03 | Melbourne Health | Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof |
EP1874923A4 (en) | 2005-04-08 | 2010-08-04 | Melbourne Health | VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
GB0611914D0 (en) | 2006-06-15 | 2006-07-26 | Teti Giuseppe | Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide |
EP2886551A3 (en) | 2008-02-21 | 2015-09-23 | Novartis AG | Meningococcal fhbp polypeptides |
GB0809659D0 (en) * | 2008-05-28 | 2008-07-02 | Univ Nottingham | Polypeptides |
RU2477145C2 (ru) | 2008-05-30 | 2013-03-10 | ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ | Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения |
RU2532911C2 (ru) | 2008-07-21 | 2014-11-20 | Дзе Брихэм Энд Уимен'З Хоспитал, Инк. | Способы и композиции, относящиеся к синтетическим бета-1,6-глюкозаминолигосахаридам |
WO2010027499A2 (en) * | 2008-09-05 | 2010-03-11 | University Of Massachusetts Medical School | Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
EP2470204B1 (en) | 2009-08-27 | 2015-12-16 | GlaxoSmithKline Biologicals SA | Hybrid polypeptides including meningococcal fhbp sequences |
WO2011039631A2 (en) | 2009-09-30 | 2011-04-07 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
BR112012010531A2 (pt) | 2009-10-27 | 2019-09-24 | Novartis Ag | "polipeptídeos de modificação meningocócica fhbp" |
BR112013005626B1 (pt) | 2010-09-10 | 2022-07-26 | Glaxosmithkline Biologicals Sa | Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição |
JP2012090571A (ja) * | 2010-10-27 | 2012-05-17 | Sekisui Chem Co Ltd | 動物の免疫方法、免疫用組成物、抗体の製造方法、並びに、ハイブリドーマの製造方法 |
NZ630133A (en) | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
HUE052293T2 (hu) | 2014-02-28 | 2021-04-28 | Glaxosmithkline Biologicals Sa | Módosított fHbp meningococcus-polipeptidek |
JP6827322B2 (ja) * | 2014-04-17 | 2021-02-10 | コーニング インコーポレイテッド | 生物学的存在の増殖のための容器 |
MX2017001279A (es) * | 2014-07-30 | 2017-08-07 | Cleveland Biolabs Inc | Usos y composiciones de la flagelina. |
JP2023542141A (ja) * | 2020-09-15 | 2023-10-05 | ザ ユニバーシティー オブ モンタナ | 繊維状バクテリオファージを標的化する組成物および方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673574A (en) * | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
WO1983003354A1 (en) * | 1982-03-30 | 1983-10-13 | Us Army | Neisseria gonorrhoeae vaccine |
EP0145359B1 (en) * | 1983-11-21 | 1991-01-16 | The Wellcome Foundation Limited | Improved complexes, processes for obtaining them and formulations containing such complexes |
US4601903A (en) * | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
RU2023448C1 (ru) * | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
AU637049B2 (en) * | 1988-05-05 | 1993-05-20 | American Cyanamid Company | Recombinant flagellin vaccines |
-
1989
- 1989-12-19 EP EP90901397A patent/EP0449958B9/en not_active Expired - Lifetime
- 1989-12-19 ES ES90901397T patent/ES2070312T5/es not_active Expired - Lifetime
- 1989-12-19 WO PCT/US1989/005678 patent/WO1990006696A2/en active IP Right Grant
- 1989-12-19 AU AU48219/90A patent/AU640118B2/en not_active Expired
- 1989-12-19 AT AT90901397T patent/ATE120093T1/de not_active IP Right Cessation
- 1989-12-19 JP JP50166290A patent/JP3436756B2/ja not_active Expired - Lifetime
- 1989-12-19 DE DE68921895T patent/DE68921895T3/de not_active Expired - Lifetime
-
1991
- 1991-06-18 NO NO912369A patent/NO305463B1/no not_active IP Right Cessation
- 1991-06-18 FI FI912965A patent/FI113009B/fi active
- 1991-06-18 DK DK199101174A patent/DK175788B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3436756B2 (ja) | 2003-08-18 |
ES2070312T3 (es) | 1995-06-01 |
ES2070312T5 (es) | 2003-05-16 |
ATE120093T1 (de) | 1995-04-15 |
WO1990006696A2 (en) | 1990-06-28 |
JPH06503465A (ja) | 1994-04-21 |
FI113009B (fi) | 2004-02-27 |
EP0449958A1 (en) | 1991-10-09 |
DK175788B1 (da) | 2005-02-21 |
EP0449958B1 (en) | 1995-03-22 |
DE68921895T2 (de) | 1995-09-07 |
DE68921895D1 (de) | 1995-04-27 |
EP0449958B2 (en) | 2002-11-13 |
AU640118B2 (en) | 1993-08-19 |
DK117491A (da) | 1991-08-15 |
NO305463B1 (no) | 1999-06-07 |
NO912369L (no) | 1991-08-06 |
WO1990006696A3 (en) | 1990-07-12 |
NO912369D0 (no) | 1991-06-18 |
FI912965A0 (fi) | 1991-06-18 |
AU4821990A (en) | 1990-07-10 |
EP0449958B9 (en) | 2003-05-28 |
DE68921895T3 (de) | 2003-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK117491A (da) | Vaccine imod meningococcussygdomme, deri indgaaende komponenter, disses anvendelse og rekombinanter, som eksprimerer dem | |
FI914129A (fi) | Nukleotidsekvens som kodar foer protein av den yttre membranen av neisseria meningitidis och an- anvaendning av naemnda protein i vaccin. | |
NO985464L (no) | Konsentrert antistoffpreparat | |
DE68924162T2 (de) | Stressproteine und verwendungen dafür. | |
DK0835133T3 (da) | Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf | |
BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
DE69934225D1 (de) | Kombinierte meningitis b/c impfstoffe | |
DK209188D0 (da) | Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel | |
HUP0102479A2 (hu) | Neisseria meningitidis-ből származó BASBO29-polinukleotid(ok) és polipeptidek | |
DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
NO881778L (no) | Enkastiner: nye glykopeptider med enkefalinase-hemmende virkning. fremgangsmaate til deres fremstilling og deres anvendelse som farmasoeytiske preparater. | |
DK0469007T3 (da) | Middel til pleje af negle, hud og hår | |
NO892015D0 (no) | Fremgangsmaate for fremstilling av et legemiddel. | |
CA2007248A1 (en) | Meningococcal class 1 outer-membrane protein vaccine | |
DK421389A (da) | Aminomethyl-peptider, deres fremstilling og anvendelse som laegemidler | |
NO912823D0 (no) | Fremgangsmaate for fremstilling av klasse ii-proteinet av neisseria meningitidis samt vaksiner som inneholder dette. | |
DK299590A (da) | Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse | |
NO912822L (no) | Fremgangsmaate for fremstilling av klasse ii-proteinet frayttermembranen til neisseria meningitidis. | |
NO912824L (no) | Fremgangsmaate for fremstilling av klasse ii-proteinet frayttermembranen til neisseria meningitidis. | |
NO922229D0 (no) | Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |